Benitec Biopharma (BNTC) Stock Chart & Stock Price History $9.40 +0.27 (+2.96%) (As of 07/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Benitec Biopharma Stock Price Performance5 Day Performance+4.91%1 Month Performance+33.33%3 Month Performance+36.23%6 Month Performance+206.19%Year-To-Date Performance+191.02%1 Year Performance+177.29% Receive BNTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Benitec Biopharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Find out details on these three critical Nvidia partners immediately. BNTC Stock Chart for Saturday, July, 27, 2024 BNTC Chart by TradingView Benitec Biopharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/26/2024$9.13$9.40+2.96%$9.71$9.2513,317 shs$88.08 million07/25/2024$9.27$9.13-1.51%$9.46$9.009,040 shs$85.55 million07/24/2024$8.99$9.27+3.11%$9.40$9.0011,421 shs$86.86 million07/23/2024$8.96$8.99+0.33%$9.47$8.8826,370 shs$84.24 million07/22/2024$9.22$8.96-2.82%$9.93$8.7629,759 shs$83.96 million07/19/2024$9.65$9.22-4.46%$9.86$8.7532,438 shs$86.37 million Get the Latest News and Ratings for BNTC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Benitec Biopharma and its competitors with MarketBeat's FREE daily newsletter. 07/18/2024$9.70$9.65-0.52%$10.11$9.5058,235 shs$90.42 million07/17/2024$10.41$9.70-6.82%$10.88$9.4060,517 shs$90.89 million07/16/2024$10.20$10.41+2.06%$10.66$9.9023,100 shs$97.54 million07/15/2024$9.47$10.20+7.71%$10.24$9.4145,487 shs$95.57 million07/12/2024$9.49$9.47-0.21%$9.70$9.1527,603 shs$88.73 million07/11/2024$9.55$9.49-0.63%$9.55$9.2521,502 shs$88.92 million07/10/2024$9.22$9.55+3.58%$9.71$9.0547,307 shs$89.48 million07/09/2024$9.67$9.22-4.65%$9.66$9.0413,959 shs$86.39 million07/08/2024$9.29$9.67+4.09%$10.04$9.2563,900 shs$90.61 million07/05/2024$8.84$9.29+5.09%$9.29$8.5716,717 shs$87.05 million07/04/2024$8.84$8.84$9.10$8.5111,027 shs$82.83 million07/03/2024$8.70$8.84+1.61%$9.10$8.5111,027 shs$82.83 million07/02/2024$7.26$8.70+19.77%$8.95$7.3158,295 shs$81.52 million07/01/2024$6.99$7.26+3.92%$7.51$6.9130,237 shs$68.06 million06/28/2024$7.05$6.99-0.85%$7.10$6.8114,532 shs$65.50 million06/27/2024$6.71$7.05+5.07%$7.06$6.663,348 shs$66.06 million06/26/2024$7.18$6.71-6.55%$7.09$6.7110,715 shs$62.86 million06/25/2024$7.21$7.18-0.42%$7.48$7.127,005 shs$67.28 million06/24/2024$6.88$7.21+4.80%$7.35$6.806,958 shs$67.56 million06/21/2024$6.30$6.88+9.21%$7.17$5.74381,454 shs$64.47 million06/20/2024$7.25$6.30-13.10%$7.43$6.2334,504 shs$59.03 million06/19/2024$7.25$7.25$7.61$7.2521,248 shs$67.93 million06/18/2024$7.47$7.25-2.95%$7.61$7.2521,242 shs$67.93 million06/17/2024$7.31$7.47+2.19%$7.57$7.2516,973 shs$69.99 million06/14/2024$7.48$7.31-2.27%$7.53$7.0927,623 shs$68.50 million06/13/2024$7.47$7.48+0.13%$8.00$7.2586,209 shs$70.09 million06/12/2024$7.50$7.47-0.40%$7.70$7.2721,121 shs$69.99 million06/11/2024$7.41$7.50+1.21%$7.98$7.2441,304 shs$70.28 million06/10/2024$7.42$7.41-0.13%$7.60$7.2318,966 shs$69.43 million06/07/2024$7.48$7.42-0.80%$7.58$7.2323,560 shs$69.51 million06/06/2024$7.49$7.48-0.13%$7.48$7.108,082 shs$70.09 million06/05/2024$7.21$7.49+3.88%$7.61$7.2020,174 shs$70.18 million06/04/2024$7.35$7.21-1.90%$7.51$6.8752,933 shs$67.56 million06/03/2024$7.65$7.35-3.92%$7.68$6.6432,955 shs$68.87 millionThe next companies to potentially benefit thanks to Nvidia are … (Ad)Nvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners.Click here to learn more.05/31/2024$7.55$7.65+1.32%$8.26$7.6041,354 shs$71.68 million05/30/2024$7.55$7.55$7.94$7.5058,082 shs$70.74 million05/29/2024$8.55$7.55-11.70%$8.55$7.55103,195 shs$70.74 million05/28/2024$9.02$8.55-5.21%$9.64$8.5188,289 shs$80.11 million05/27/2024$9.02$9.02$9.56$9.0211,100 shs$84.52 million05/24/2024$9.41$9.02-4.14%$9.56$9.0211,192 shs$84.52 million05/23/2024$9.49$9.41-0.84%$9.70$9.0010,211 shs$88.17 million05/22/2024$9.60$9.49-1.15%$10.04$9.3225,370 shs$88.92 million05/21/2024$10.47$9.60-8.31%$10.49$9.5017,698 shs$89.95 million05/20/2024$9.49$10.47+10.33%$10.70$9.4758,355 shs$98.10 million05/17/2024$9.47$9.49+0.21%$9.60$9.1624,531 shs$88.92 million05/16/2024$8.85$9.47+7.01%$9.67$8.6545,830 shs$24.53 million05/15/2024$8.43$8.85+4.98%$9.12$8.4218,417 shs$22.92 million05/14/2024$8.12$8.43+3.82%$8.43$7.7117,251 shs$21.83 million05/13/2024$9.25$8.12-12.22%$9.03$7.4687,780 shs$21.03 million05/10/2024$9.18$9.25+0.76%$9.43$8.6533,403 shs$23.98 million05/09/2024$8.64$9.18+6.25%$9.46$8.6143,145 shs$23.80 million05/08/2024$8.15$8.64+6.01%$8.76$8.0315,602 shs$22.38 million05/07/2024$8.32$8.15-2.04%$8.28$8.0111,205 shs$21.11 million05/06/2024$8.95$8.32-7.04%$9.82$7.8936,874 shs$21.55 million05/03/2024$8.87$8.95+0.90%$10.29$8.5578,414 shs$23.18 million05/02/2024$7.90$8.87+12.28%$9.46$8.1560,606 shs$22.97 million05/01/2024$8.45$7.90-6.51%$8.82$7.5538,109 shs$20.46 million04/30/2024$7.45$8.45+13.42%$8.50$7.5284,765 shs$21.89 million04/29/2024$6.90$7.45+7.97%$7.55$6.9026,948 shs$19.30 million04/26/2024$6.90$6.98+1.16%$7.00$6.7119,769 shs$18.08 million Related Companies: ACIU Stock Price Chart KMDA Stock Price Chart INZY Stock Price Chart NKTX Stock Price Chart XOMA Stock Price Chart AMRN Stock Price Chart ALXO Stock Price Chart MGNX Stock Price Chart ENTA Stock Price Chart AVIR Stock Price Chart Receive BNTC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Benitec Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BNTC) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored4 Steps to Survive the Coming Market CrashCracks threaten us with a widespread collapse unlike anything we've seen in our lifetime. During this prese...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Benitec Biopharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Benitec Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.